2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

被引:4966
作者
Aletaha, Daniel [2 ]
Neogi, Tuhina [3 ]
Silman, Alan J. [1 ]
Funovits, Julia [2 ]
Felson, David T. [3 ]
Bingham, Clifton O., III [4 ]
Birnbaum, Neal S. [5 ,6 ]
Burmester, Gerd R. [7 ,8 ]
Bykerk, Vivian P. [9 ,10 ]
Cohen, Marc D. [11 ]
Combe, Bernard [12 ,13 ]
Costenbader, Karen H. [14 ,15 ]
Dougados, Maxime [16 ,17 ]
Emery, Paul [18 ,19 ]
Ferraccioli, Gianfranco [20 ]
Hazes, Johanna M. W. [21 ,22 ]
Hobbs, Kathryn [23 ]
Huizinga, Tom W. J. [24 ]
Kavanaugh, Arthur [25 ]
Kay, Jonathan [26 ,27 ]
Kvien, Tore K. [28 ]
Laing, Timothy [29 ]
Mease, Philip [30 ,31 ]
Menard, Henri A. [32 ]
Moreland, Larry W. [33 ]
Naden, Raymond L. [34 ]
Pincus, Theodore [35 ]
Smolen, Josef S. [2 ]
Stanislawska-Biernat, Ewa [36 ]
Symmons, Deborah [37 ]
Tak, Paul P. [38 ]
Upchurch, Katherine S. [26 ,27 ]
Vencovsky, Jiri [39 ]
Wolfe, Frederick [40 ,41 ]
Hawker, Gillian [10 ,42 ]
机构
[1] Arthrit Res UK, Chesterfield S41 7TD, England
[2] Med Univ Vienna, Vienna, Austria
[3] Boston Univ, Sch Med, Boston, MA 02118 USA
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Calif Pacific Med Ctr, San Francisco, CA USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Free Univ Berlin, Charite Hosp Univ Med Berlin, D-1000 Berlin, Germany
[8] Humboldt Univ, Berlin, Germany
[9] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[10] Univ Toronto, Toronto, ON, Canada
[11] Natl Jewish Med & Res Ctr, Denver, CO USA
[12] Lapeyronie Hosp, Montpellier, France
[13] Univ Montpellier I, Montpellier, France
[14] Brigham & Womens Hosp, Boston, MA 02115 USA
[15] Harvard Univ, Boston, MA 02115 USA
[16] Cochin Hosp, AP HP, Paris, France
[17] Paris Descartes Univ, Paris, France
[18] Univ Leeds, Leeds, W Yorkshire, England
[19] NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[20] Univ Cattolica Sacro Cuore, Sch Med, I-00168 Rome, Italy
[21] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Rotterdam, Netherlands
[22] Univ Rotterdam, Rotterdam, Netherlands
[23] Univ Colorado, Sch Med, Denver, CO 80202 USA
[24] Leiden Univ, Med Ctr, Leiden, Netherlands
[25] Univ Calif San Diego, San Diego, CA 92103 USA
[26] UMassMem Med Ctr, Worcester, MA USA
[27] Univ Massachusetts, Sch Med, Worcester, MA USA
[28] Diakonhjemmet Hosp, Oslo, Norway
[29] Univ Michigan, Ann Arbor, MI 48109 USA
[30] Swedish Med Ctr, Seattle, WA USA
[31] Univ Washington, Seattle, WA 98195 USA
[32] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[33] Univ Pittsburgh, Pittsburgh, PA USA
[34] Minist Hlth, Auckland, New Zealand
[35] New York Univ Hosp Joint Dis, New York, NY USA
[36] Inst Rheumatol, Warsaw, Poland
[37] Univ Manchester, Manchester, Lancs, England
[38] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[39] Inst Rheumatol, Prague, Czech Republic
[40] Natl Data Bank Rheumat Dis, Wichita, KS USA
[41] Univ Kansas, Wichita, KS USA
[42] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada
来源
ARTHRITIS AND RHEUMATISM | 2010年 / 62卷 / 09期
关键词
UNDIFFERENTIATED ARTHRITIS; CITRULLINATED PEPTIDE; CONTROLLED-TRIAL; METHOTREXATE; DISEASE; PROGRESSION; ANTIBODIES; THERAPIES; EROSIONS;
D O I
10.1002/art.27584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The 1987 American College of Rheumatology (ACR; formerly, the American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized for their lack of sensitivity in early disease. This work was undertaken to develop new classification criteria for RA. Methods. A joint working group from the ACR and the European League Against Rheumatism developed, in 3 phases, a new approach to classifying RA. The work focused on identifying, among patients newly presenting with undifferentiated inflammatory synovitis, factors that best discriminated between those who were and those who were not at high risk for persistent and/or erosive disease-this being the appropriate current paradigm underlying the disease construct "rheumatoid arthritis." Results. In the new criteria set, classification as "definite RA" is based on the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints (score range 0-5), serologic abnormality (score range 0-3), elevated acute-phase response (score range 0-1), and symptom duration (2 levels; range 0-1). Conclusion. This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features. This will refocus attention on the important need for earlier diagnosis and institution of effective disease-suppressing therapy to prevent or minimize the occurrence of the undesirable sequelae that currently comprise the paradigm underlying the disease construct "rheumatoid arthritis."
引用
收藏
页码:2569 / 2581
页数:13
相关论文
共 32 条
[1]   Anti-Citrullinated Peptide Antibody Assays and Their Role in the Diagnosis of Rheumatoid Arthritis [J].
Aggarwal, Rohit ;
Liao, Katherine ;
Nair, Raj ;
Ringold, Sarah ;
Costenbader, Karen H. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (11) :1472-1483
[2]  
AHO K, 1991, J RHEUMATOL, V18, P1282
[3]  
AHO K, 1993, J RHEUMATOL, V20, P1278
[4]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[5]   Optimal use of methotrexate: the advantages of tight control [J].
Bijlsma, Johannes W. J. ;
Weinblatt, Michael E. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) :1409-1410
[6]   Diagnostic radiography in rheumatoid arthritis: Benefits and limitations [J].
Bohndorf, K ;
Schalm, J .
BAILLIERES CLINICAL RHEUMATOLOGY, 1996, 10 (03) :399-407
[7]   Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years - Results from a large observational inception study [J].
Bukhari, MAS ;
Wiles, NJ ;
Lunt, M ;
Harrison, BJ ;
Scott, DGI ;
Symmons, DPM ;
Silman, AJ .
ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :46-53
[8]   Rheumatoid arthritis: An overview of new and emerging therapies [J].
Doan, T ;
Massarotti, E .
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (07) :751-762
[9]   Evolving concepts of rheumatoid arthritis [J].
Firestein, GS .
NATURE, 2003, 423 (6937) :356-361
[10]   The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I [J].
Funovits, Julia ;
Aletaha, Daniel ;
Bykerk, Vivian ;
Combe, Bernard ;
Dougados, Maxime ;
Emery, Paul ;
Felson, David ;
Hawker, Gillian ;
Hazes, Joanna M. ;
Huizinga, Tom ;
Kay, Jonathan ;
Kvien, Tore K. ;
Smolen, Josef S. ;
Symmons, Deborah ;
Tak, Paul P. ;
Silman, Alan .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (09) :1589-1595